BackArcturus Therapeutics Holdings Overview
Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics Holdings Target Price

See Arcturus Therapeutics Holdings's analyst price targets ($41) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$14.38

Average Target Price

$41.00185.1% upside

1 analysts in the last 4 months

High: $41 | Low: $41

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-02Roth Capital$41185.1% upsideOpen
2026-03-04Piper SandlerYasmeen Rahimi$2573.9% upsideOpen
2026-01-22Roth Capital$2039.1% upsideOpen
2025-08-22Leerink PartnersLili Nsongo$54275.5% upsideOpen
2025-05-28ScotiabankGreg Harrison$32122.5% upsideOpen
2025-03-10BTIGThomas Shrader$48233.8% upsideOpen
2024-11-11Canaccord GenuityWhitney Ijem$10.5826.4% downsideOpen
2024-08-06Canaccord GenuityWhitney Ijem$10.328.4% downsideOpen
2024-07-02H.C. WainwrightEd Arce$8.5840.3% downsideOpen
2024-05-31Piper SandlerYasmeen Rahimi$20.0239.2% upsideOpen
2024-05-10Canaccord GenuityWhitney Ijem$12.314.5% downsideOpen
2024-03-19LaidlawYale Jen$11.321.4% downsideOpen
2022-11-02BarclaysGena Wang$2573.9% upsideOpen
2022-05-11Goldman Sachs$142.6% downsideOpen
2021-11-09Goldman SachsMadhu Kumar$30108.6% upsideOpen

Arcturus Therapeutics Holdings (ARCT) FAQ

Arcturus Therapeutics Holdings (ARCT) currently reports a target price of $41. Use the charts on this page to explore Arcturus Therapeutics Holdings's target price history and peer comparisons.

Analysts' average 12-month price target for Arcturus Therapeutics Holdings is $41, about 185.1% upside from the current share price of $14.38. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $41, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Arcturus Therapeutics Holdings, and consider following ARCT for alerts when major investors trade the stock.

Arcturus Therapeutics Holdings is classified in the Healthcare sector. On target price, it currently shows $41. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ARCT with unrelated industries.